- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/02 - ThiadiazolesHydrogenated thiadiazoles
Patent holdings for IPC class C07D 285/02
Total number of patents in this class: 16
10-year publication summary
|
1
|
0
|
1
|
1
|
0
|
0
|
2
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Green Cross Corporation | 219 |
3 |
| Changchun Institute of Applied Chemistry Chinese Academy of Sciences | 115 |
2 |
| Danatlas Pharmaceuticals Co., Ltd. | 26 |
2 |
| Boehringer Ingelheim International GmbH | 4485 |
1 |
| Dow AgroSciences LLC | 1179 |
1 |
| Abbvie Inc. | 1799 |
1 |
| Mayo Foundation for Medical Education and Research | 3398 |
1 |
| Centro Nacional de Investigaciones Oncologicas (CNIO) | 30 |
1 |
| U.S. Army Medical Research and Materiel Command | 10 |
1 |
| Calico Life Sciences LLC | 118 |
1 |
| Corteva Agriscience LLC | 2646 |
1 |
| Beijing Danatlas Pharmaceutical Co., Ltd. | 1 |
1 |
| Other owners | 0 |